The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).
Allen NM, O'Rahelly M, Eymard B, Chouchane M, Hahn A, Kearns G, Kim DS, Byun SY, Nguyen CE, Schara-Schmidt U, Kölbel H, Marina AD, Schneider-Gold C, Roefke K, Thieme A, Van den Bergh P, Avalos G, Álvarez-Velasco R, Natera-de Benito D, Cheng MHM, Chan WK, Wan HS, Thomas MA, Borch L, Lauzon J, Kornblum C, Reimann J, Mueller A, Kuntzer T, Norwood F, Ramdas S, Jacobson LW, Jie X, Fernandez-Garcia MA, Wraige E, Lim M, Lin JP, Claeys KG, Aktas S, Oskoui M, Hacohen Y, Masud A, Leite MI, Palace J, De Vivo D, Vincent A, Jungbluth H.
Brain. 2023 Oct 3;146(10):4233-4246. doi: 10.1093/brain/awad153.
Myasthenia gravis: the future is here.
Kaminski HJ, Sikorski P, Coronel SI, Kusner LL.
J Clin Invest. 2024 Jun 17;134(12):e179742. doi: 10.1172/JCI179742.
Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders.
Pechlivanidou M, Vakrakou AG, Karagiorgou K, Tüzün E, Karachaliou E, Chroni E, Afrantou T, Grigoriadis N, Argyropoulou C, Paschalidis N, Şanlı E, Tsantila A, Dandoulaki M, Ninou EI, Zisimopoulou P, Mantegazza R, Andreetta F, Dudeck L, Steiner J, Lindstrom JM, Tzanetakos D, Voumvourakis K, Giannopoulos S, Tsivgoulis G, Tzartos SJ, Tzartos J.
Front Immunol. 2024 May 28;15:1388998. doi: 10.3389/fimmu.2024.1388998. eCollection 2024.
Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders.
Mané-Damas M, Molenaar PC, Ulrichts P, Marcuse F, De Baets MH, Martinez-Martinez P, Losen M.
Autoimmun Rev. 2022 Jul;21(7):103104. doi: 10.1016/j.autrev.2022.103104. Epub 2022 Apr 19.
Autoimmune Autonomic Disorders.
Vernino S.
Continuum (Minneap Minn). 2020 Feb;26(1):44-57. doi: 10.1212/CON.0000000000000812.
Autoimmune Neurogenic Dysphagia.
Stathopoulos P, Dalakas MC.
Dysphagia. 2022 Jun;37(3):473-487. doi: 10.1007/s00455-021-10338-9. Epub 2021 Jul 5.
A retrospective study of acetylcholine receptor antibody positive ocular myasthenia in the West of Scotland.
Farrugia ME, Cleary M, Carmichael C.
J Neurol Sci. 2017 Nov 15;382:84-86. doi: 10.1016/j.jns.2017.09.036. Epub 2017 Sep 27.
Advances in autoimmune myasthenia gravis management.
Wang S, Breskovska I, Gandhy S, Punga AR, Guptill JT, Kaminski HJ.
Expert Rev Neurother. 2018 Jul;18(7):573-588. doi: 10.1080/14737175.2018.1491310. Epub 2018 Jul 4.
99mTc-Tricarbonyl-K-H-K-H-cholecystokinin 8.
Chopra A.
2008 Jul 14 [updated 2008 Aug 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
Novel pathophysiological insights in autoimmune myasthenia gravis.
Masi G, O'Connor KC.
Curr Opin Neurol. 2022 Oct 1;35(5):586-596. doi: 10.1097/WCO.0000000000001088. Epub 2022 Aug 4.
